These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13162574)

  • 1. Specific tissue alteration in leprous skin. V. Preliminary note on specific reactions following the inoculation of living microorganisms (isopathic phenomenon).
    SAGHER F; LIBAN E; ZUCKERMAN A; KOCSARD E
    Int J Lepr; 1953; 21(4:1):459-62. PubMed ID: 13162574
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific tissue alteration in leprous skin. VI. Isopathic phenomenon following BCG vaccination in leprous patients.
    SAGHER F; LIBAN E; KOCSARD E
    AMA Arch Derm Syphilol; 1954 Nov; 70(5):631-9. PubMed ID: 13206405
    [No Abstract]   [Full Text] [Related]  

  • 3. 'Isopathic phenomenon' in leprosy.
    Rao BN; Satyanarayana BV; Venkatarathnam G; Reddy CR
    Dermatologica; 1975; 150(3):169-75. PubMed ID: 1158013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific tissue alteration in leprous skin. VII. Inoculation of Leishmania tropica into leprous patients.
    LIBAN E; ZUCKERMAN A; SAGHER F
    AMA Arch Derm; 1955 Apr; 71(4):441-50. PubMed ID: 14360751
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rapid appearance of many cases of tuberculoid leprosy in children recently vaccinated with BCG in country with leprous endemicity].
    FLOCH H; MAILLOUX M
    Publ Inst Pasteur Guyane Fr Inini; 1958 Jun; 19(447):1-6. PubMed ID: 13628239
    [No Abstract]   [Full Text] [Related]  

  • 6. [BCG in prevention of leprosy; spontaneous positivity; positivity after re-inoculation with Mitsuda antigen; practical results currently observed].
    DE CAMPOS NS
    Rev Bras Leprol; 1956; 24(4):173-87. PubMed ID: 13420748
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG in the prophylaxis of leprosy; a preliminary report.
    DE SOUZA CAMPOS N
    Int J Lepr; 1953; 21(3):307-12. PubMed ID: 13108342
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE ISOPATHIC PHENOMENON OF SAGHER. PRELIMINARY REPORT ON LEPROSY PATIENTS IN THE PHILIPPINES.
    REYES-JAVIER PD
    Lepr Rev; 1964 Apr; 35():97-102. PubMed ID: 14143118
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific tissue alteration in leprous skin. II. The histology of the tuberculin reaction in leprosy.
    SAGHER F; KOCSARD E; LIBAN E
    J Invest Dermatol; 1952 Dec; 19(6):499-508. PubMed ID: 13023022
    [No Abstract]   [Full Text] [Related]  

  • 15. Leprosy and tuberculosis: a comparative study with the aid of skin tests with tuberculin, killed BCG, and the Dharmendra lepromin in South African Bantus.
    KOOIJ R; RUTGERS AW
    Int J Lepr; 1958; 26(1):24-40. PubMed ID: 13586953
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Sagher on the "Isopathic phenomenon" in lepromatous leprosy.
    KOOIJ R; PEPLER WJ
    Dermatologica; 1963; 126():268-70. PubMed ID: 14034668
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cortisone in therapy of leprous reaction; preliminary note].
    IGLESIA MH
    Rev Asoc Med Argent; 1954 Mar 15-30; 68(769-770):55-7. PubMed ID: 13178067
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific tissue alteration in leprous skin. III. Specific reaction due to various agents.
    SAGHER F; LIBAN E; KOCSARD E
    J Invest Dermatol; 1953 May; 20(5):343-52. PubMed ID: 13052985
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunoelectrophoretic analysis of leprous serums in Guadaloupe. Preliminary note].
    Carteron B; Fauran P; Courmes E
    Med Trop (Mars); 1970; 30(3):347-52. PubMed ID: 5432030
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of BCG vaccination among leprosy contacts: a cohort study.
    Düppre NC; Camacho LA; da Cunha SS; Struchiner CJ; Sales AM; Nery JA; Sarno EN
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):631-8. PubMed ID: 18514242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.